Table 3 Intraoperative and post-operative inotropic agent usages
|  | Control group (n = 200) | Ulinastatin group (n = 100) | P value |
|---|---|---|---|
Intraoperative usage | Â | Â | Â |
Norepinephrine | 154 (77.0%) | 78 (78.0%) |  > 0.999 |
Vasopressin | 14 (7.0%) | 6 (6.0%) | 0.774 |
Dobutamine | 4 (2.0%) | 1 (1.0%) |  > 0.999 |
Milrinone | 8 (4.0%) | 6 (6.0%) | 0.517 |
Immediate post operation | Â | Â | Â |
Norepinephrine | 60 (30.0%) | 28 (28.0%) | 0.706 |
Vasopressin | 0 (0.0%) | 0 (0.0%) | 1.000 |
Dobutamine | 0 (0.0%) | 1 (1.0%) | 1.000 |
Milrinone | 14 (7.0%) | 4 (4.0%) | 0.234 |
Post-operative day 1 | Â | Â | Â |
Norepinephrine | 122 (61.0%) | 53 (53.0%) | 0.263 |
Vasopressin | 4 (2.0%) | 0 (0.0%) | 0.121 |
Dobutamine | 2 (1.0%) | 2 (2.0%) | 1.000 |
Milrinone | 24 (12.0%) | 8 (8.0%) | 0.347 |
Post-operative day 2 | Â | Â | Â |
Norepinephrine | 76 (38.0%) | 33 (33.0%) | 0.468 |
Vasopressin | 4 (2.0%) | 1 (1.0%) | 0.369 |
Dobutamine | 0 (0.0%) | 1 (1.0%) | 1.000 |
Milrinone | 14 (7.0%) | 5 (5.0%) | 0.552 |
Post-operative day 3 | Â | Â | Â |
Norepinephrine | 50 (25.0%) | 20 (20.0%) | 0.407 |
Vasopressin | 1 (0.5%) | 0 (0.0%) | 1.000 |
Dobutamine | 2 (1.0%) | 2 (2.0%) | 1.000 |
Milrinone | 12 (6.0%) | 2 (2.0%) | 0.279 |